Cargando…
Optogenetic neuromodulation with gamma oscillation as a new strategy for Alzheimer disease: a narrative review
The amyloid hypothesis has been considered a major explanation of the pathogenesis of Alzheimer disease. However, failure of phase III clinical trials with anti-amyloid-beta monoclonal antibodies reveals the need for other therapeutic approaches to treat Alzheimer disease. Compared to its relatively...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Journal of Yeungnam Medical Science
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9580057/ https://www.ncbi.nlm.nih.gov/pubmed/35152662 http://dx.doi.org/10.12701/jyms.2021.01683 |